Status:
WITHDRAWN
Long Term Effects of Nutritional Supplementation on Final Height
Lead Sponsor:
Rabin Medical Center
Conditions:
Growth Disorders
Low Weight
Eligibility:
All Genders
10-15 years
Phase:
NA
Brief Summary
The proposed study is an extension study to two ongoing double blind, randomized, placebo-controlled studies evaluating the effect of gender-specific nutritional supplementation on growth of short and...
Eligibility Criteria
Inclusion
- Participation in the former double blind, randomized, placebo controlled study to evaluate the effect of nutritional supplementation on growth of short and lean adolescent boys (protocol no. 0676-14) and girls (protocol no. 0002-15).
- Completing at least the double blind phase of the previous studies (protocol no 0676- 14 or 0002-15)
- Signing informed consent forme
Exclusion
- Diagnosis of Growth Hormone Deficiency or treatment with Growth Hormone
- Any known chronic disease or dysmorphic syndrome including: bone diseases, organic brain diseases, neurological disease, past or current malignancy, chronic cardiac, renal or pulmonary problems
- Any known gastrointestinal disease including malabsorption
- Any known organic reason for growth retardation
- Any chronic treatment with medication that might affect appetite, weight or growth
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03323177
Start Date
June 1 2018
End Date
June 1 2022
Last Update
December 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schneider Children's Medical Center
Petah Tikva, Israel, 49202